Skip to main content

Table 1 Demographic, clinical and dietary variables of study participants

From: Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss

  Control (n = 17) HCD (n = 17) P
Age (years) 56 ± 1 55 ± 1 0.87
Gender (M/F) 10/7 7/10 0.49
Number of MetS components 2.7 ± 0.3 2.5 ± 0.3 0.68
Clinical parameters
 Body weight (kg) 97.8 ± 4.0 98.6 ± 4.1 0.89
 Body mass index (kg/m2) 32.8 ± 0.9 33.9 ± 1.7 0.85
 Waist circumference (cm) 106.1 ± 2.3 107.8 ± 2.8 0.63
 Waist to hip ratio 0.91 ± 0.02 0.91 ± 0.02 0.96
 Fasting glucose (mmol/L) 5.8 ± 0.1 6.1 ± 0.2 0.24
 2-h glucose (mmol/L) 9.6 ± 0.7 10.4 ± 0.7 0.44
 Fasting insulin (mU/L) 17.7 ± 1.6 18.0 ± 1.4 0.88
 HOMA-IR 4.8 ± 0.4 4.9 ± 0.5 0.90
 M (mg kg FFM min−1) 9.49 ± 0.82 10.24 ± 0.93 0.55
 Insulin clearance (mL m2 min−1) 382 ± 20 352 ± 14 0.23
 Triglycerides (mmol/L) 1.5 ± 0.1 1.7 ± 0.2 0.77
 HDL-cholesterol (mmol/L) 1.29 ± 0.07 1.20 ± 0.06 0.44
 LDL-cholesterol (mmol/L) 3.4 ± 0.1 3.9 ± 0.2 0.07
Clinic systolic BP (mmHg) 127 ± 4 121 ± 2 0.22
 Clinic diastolic BP (mmHg) 72 ± 2 69 ± 2 0.27
 Clinic heart rate (bpm) 62 ± 2 62 ± 2 0.92
 7-day pedometry (steps per day) 8021 ± 724 8824 ± 1100 0.68
Habitual dietary intake
 Energy (kcal/day) 2081 ± 158 2067 ± 86 0.69
 Fat (% energy) 34 ± 2 36 ± 1 0.32
 Saturated fat (% energy) 14 ± 1 15 ± 1 0.46
 Protein (% energy) 19 ± 1 18 ± 1 0.83
 Carbohydrate (% energy) 44 ± 2 41 ± 2 0.28
 Alcohol (% energy) 2 ± 1 2 ± 1 0.74
 24-h urinary sodium (mmol/day) 155 ± 20 157 ± 14 0.58
  1. BP blood pressure, HOMA-IR homeostasis model assessment of insulin resistance, M steady state glucose utilization during euglycemic hyperinsulinemic clamp (mg per kg fat free mass per minute), MetS metabolic syndrome components defined as per harmonized definition